• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ARCHITECT ANTI-HCV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ARCHITECT ANTI-HCV Back to Search Results
Model Number 1L79-25
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/11/2019
Event Type  malfunction  
Manufacturer Narrative
Patient information: no further patient information was provided by the customer.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer observed a false nonreactive architect anti-hcv result for 1 patient.A different sample from another laboratory was reactive.No impact to patient management was reported.
 
Manufacturer Narrative
A review of tickets was performed for reagent lot number 07124be00.The ticket search determined that there is normal complaint activity for the likely cause lot.A review of tracking and trending did not identify any trends for the complaint issue.Return testing was not completed as returns were not available.Retained reagent kits of lot number 07124be00 were tested in a sensitivity setup including two sensitivity panels and the positive control on two analyzers.All values met specifications and all results were in the typical range and no false nonreactive results were obtained.Additionally, two commercially available seroconversion panels were tested on one analyzer.The results were compared to architect anti-hcv test results provided by the panel manufacturer.The reagent detected the same bleeds as reactive with comparable s/co values for the seroconversion panels.A review of the manufacturing documentation did not identify any issues associated with the complaint issue.A review of labeling concluded that the issue is sufficiently addressed.Based on the investigation no systemic issue or deficiency of the architect anti-hcv reagent, lot number 07124be00 was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT ANTI-HCV
Type of Device
ANTI-HCV
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key9526965
MDR Text Key190485703
Report Number3002809144-2019-01094
Device Sequence Number1
Product Code MZO
UDI-Device Identifier00380740001414
UDI-Public00380740001414
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 03/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/25/2020
Device Model Number1L79-25
Device Catalogue Number01L79-25
Device Lot Number07124BE00
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/18/2019
Initial Date FDA Received12/27/2019
Supplement Dates Manufacturer Received03/16/2020
Supplement Dates FDA Received03/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I1000SR PROCESSING MODULE; ARCHITECT I1000SR PROCESSING MODULE; LIST 01L86-01, SERIAL (B)(4).; LIST 01L86-01, SERIAL (B)(4).
-
-